Clinical trial NCT04629235: Reduction of Bedrest Time of Post Percutaneous Renal Biopsy Patients
Official title: Reduction of Bedrest Time of Post Percutaneous Renal Biopsy Patients (RBP) Evaluated by Nursing Outcomes Classification (NOC): a Randomized Clinical Trial
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Bedrest
Keywords: Renal Biopsy
Complications
Standardized Nursing Terminology
Lead sponsor: Hospital de Clinicas de Porto Alegre
Sponsor class: OTHER
First posted: 2020-11-16
Enrollment: 140
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: To compare the reduction of the bedrest time of the patient after percutaneous renal biopsy from 24 hours to 8 hours in relation to the occurrence of complications evaluated by the Nursing Outcome Classification (NOC) indicators.

Detailed description: Percutaneous renal biopsy (BRP) is an important procedure for the diagnosis, prognostic evaluation and therapeutic orientation of several kidney diseases. Although it is considered a safe procedure, BRP complications can occur and, most of the time, are related to the risk of bleeding and the main consequence of BRP. Complications include macroscopic hematuria and hematoma requiring blood transfusion, surgical intervention, or invasive procedure. Since hemorrhagic complications continue to be the highest risk after BRP due to severity and potential life-threatening risk, there is an effort to minimize the risk of bleeding by checking blood clotting markers prior to the procedure, uncontrolled hypertension and the use of antiplatelet drugs and anticoagulants. The relevance of this study is to seek better evidence for clinical practice, considering the lack of Brazilian studies on the subject and the positive impact on patient comfort, besides the reduction of costs for the institution and overload in the work of the multidisciplinary team. In addition, it will contribute to the strengthening of the use of NOC in clinical practice and to the improvement of nursing knowledge.

Eligibility criteria: Inclusion Criteria:

* All patients undergoing renal biopsy at Hospital de Clínicas de Porto Alegre (HCPA);
* Both sexes;
* Aged 18 years or older.

Exclusion Criteria:

* Patients with the following risk factors for complications;
* More than two punctures during the procedure;
* Larger gauge needle;
* Uncontrolled blood pressure;
* Blood clotting disorders and use of antiplatelet agents (aspirin or clopidogrel), or use of anticoagulants;
* Bedridden patients and patients unable to adequately to ambulate.

Primary outcomes:
measure: NOC Blood coagulation (0409)
timeFrame: 24 hours
Secondary outcomes:
measure: NOC Circulation status (0401)
timeFrame: 24 hours
measure: NOC Pain level (2102) as assessed by Visual Analog Pain Scale or Numerical Verbal Pain Scale, asking how much they rate their pain from 0 to 10
timeFrame: 24 hours
measure: NOC Comfort status: physical (2010)
timeFrame: 24 hours
Other outcomes:
Locations:
city: Porto Alegre
country: Brazil
facility: Hospital de Clínicas de Porto Alegre
state: Rio Grande Do Sul
Study officials:
affiliation: Hospital de Clínicas de Porto Alegre
name: Amália de Fátima Lucena
role: PRINCIPAL_INVESTIGATOR
References: